bioAffinity Technologies (BIAF) Asset Utilization Ratio (2023 - 2026)

bioAffinity Technologies has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.6 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 59.01% year-over-year to 0.6; the TTM figure through Mar 2026 stood at 0.6 (down 59.01% YoY), while the FY2025 annual figure was 0.71, down 44.5% from the prior year.
• Asset Utilization Ratio improved to 0.6 in Q1 2026, from 0.55 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for BIAF reached as high as 1.49 in Q2 2025 and fell as low as 0.0 in Q1 2023.
• The 4-year median for Asset Utilization Ratio is 0.61 (2024), against an average of 0.75.
• Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 119993.65% — and 2025, when it sank 61.79%.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.28 in 2023, then jumped by 420.91% to 1.43 in 2024, then slumped by 61.79% to 0.55 in 2025, then grew by 9.35% to 0.6 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.6, 0.55, and 0.83 for Q1 2026, Q4 2025, and Q3 2025 respectively.